Share-based Payment Arrangement, Expense in USD of STANDARD BIOTOOLS INC. from Q2 2011 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Standard Biotools Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from Q2 2011 to Q3 2025.
  • Standard Biotools Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $7.54M, a 62.1% increase year-over-year.
  • Standard Biotools Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $34M, a 46.8% increase year-over-year.
  • Standard Biotools Inc. annual Share-based Payment Arrangement, Expense for 2024 was $31.7M, a 142% increase from 2023.
  • Standard Biotools Inc. annual Share-based Payment Arrangement, Expense for 2023 was $13.1M, a 11.8% decline from 2022.
  • Standard Biotools Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14.9M, a 7.58% decline from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

STANDARD BIOTOOLS INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $34M $7.54M +$2.89M +62.1% 01 Jul 2025 30 Sep 2025 10-Q 04 Nov 2025
Q2 2025 $31.1M $5.37M +$1.96M +57.5% 01 Apr 2025 30 Jun 2025 10-Q 15 Aug 2025
Q1 2025 $29.1M $9.01M -$2.6M -22.4% 01 Jan 2025 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $31.7M $12.1M +$8.59M +247% 01 Oct 2024 31 Dec 2024 10-K 11 Mar 2025
Q3 2024 $23.1M $4.65M +$1.26M +37.3% 01 Jul 2024 30 Sep 2024 10-Q 04 Nov 2025
Q2 2024 $21.9M $3.41M +$296K +9.51% 01 Apr 2024 30 Jun 2024 10-Q 15 Aug 2025
Q1 2024 $21.6M $11.6M +$8.46M +269% 01 Jan 2024 31 Mar 2024 10-Q 06 May 2025
Q4 2023 $13.1M $3.48M +$1.79M +107% 01 Oct 2023 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $11.3M $3.39M -$1.11M -24.7% 01 Jul 2023 30 Sep 2023 10-Q 06 Nov 2024
Q2 2023 $12.4M $3.11M -$1.55M -33.2% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 $14M $3.15M -$894K -22.1% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $14.9M $1.68M -$2.68M -61.5% 01 Oct 2022 31 Dec 2022 10-K 11 Mar 2025
Q3 2022 $17.6M $4.49M +$174K +4.03% 01 Jul 2022 30 Sep 2022 10-Q 07 Nov 2023
Q2 2022 $17.4M $4.66M +$922K +24.6% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 $16.5M $4.04M +$365K +9.93% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 $16.1M $4.36M +$269K +6.57% 01 Oct 2021 31 Dec 2021 10-K 14 Mar 2023
Q3 2021 $15.8M $4.32M -$37K -0.85% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $15.9M $3.74M +$107K +2.94% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $15.8M $3.68M +$1.31M +55.4% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 $14.5M $4.09M +$993K +32% 01 Oct 2020 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $13.5M $4.36M +$1.33M +43.8% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021
Q2 2020 $12.1M $3.63M +$642K +21.5% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $11.5M $2.37M +$95K +4.18% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $11.4M $3.1M -$1.87M -37.6% 01 Oct 2019 31 Dec 2019 10-K 08 Mar 2022
Q3 2019 $13.3M $3.03M +$726K +31.5% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020
Q2 2019 $12.5M $2.99M +$985K +49.1% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020
Q1 2019 $11.5M $2.27M +$524K +30% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 $11M $4.97M +$2.87M +137% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021
Q3 2018 $8.15M $2.3M +$3K +0.13% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 $8.15M $2.01M -$293K -12.7% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 $8.44M $1.75M -$653K -27.2% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019
Q4 2017 $9.09M $2.09M -$766K -26.8% 01 Oct 2017 31 Dec 2017 10-K 27 Feb 2020
Q3 2017 $9.86M $2.3M -$1.3M -36.1% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 $11.2M $2.3M -$1.4M -37.8% 01 Apr 2017 30 Jun 2017 10-Q 08 Aug 2018
Q1 2017 $12.6M $2.4M -$1.3M -35.1% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018
Q4 2016 $13.9M $2.86M 01 Oct 2016 31 Dec 2016 10-K 18 Mar 2019
Q3 2016 $3.6M -$500K -12.2% 01 Jul 2016 30 Sep 2016 10-Q 07 Nov 2017
Q2 2016 $3.7M -$900K -19.6% 01 Apr 2016 30 Jun 2016 10-Q 08 Aug 2017
Q1 2016 $3.7M -$400K -9.76% 01 Jan 2016 31 Mar 2016 10-Q 09 May 2017
Q3 2015 $4.1M -$1.9M -31.7% 01 Jul 2015 30 Sep 2015 10-Q 09 Nov 2016
Q2 2015 $4.6M -$1.3M -22% 01 Apr 2015 30 Jun 2015 10-Q 09 Aug 2016
Q1 2015 $4.1M +$700K +20.6% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q3 2014 $6M +$4.3M +253% 01 Jul 2014 30 Sep 2014 10-Q 09 Nov 2015
Q2 2014 $5.9M +$4.2M +247% 01 Apr 2014 30 Jun 2014 10-Q 10 Aug 2015
Q1 2014 $3.4M +$2.1M +162% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q3 2013 $1.7M +$700K +70% 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 $1.7M +$600K +54.5% 01 Apr 2013 30 Jun 2013 10-Q 04 Aug 2014
Q1 2013 $1.3M +$400K +44.4% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q3 2012 $1M +$300K +42.9% 01 Jul 2012 30 Sep 2012 10-Q 07 Nov 2013
Q2 2012 $1.1M +$600K +120% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013
Q1 2012 $900K 01 Jan 2012 31 Mar 2012 10-Q 09 May 2013
Q3 2011 $700K 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $500K 01 Apr 2011 30 Jun 2011 10-Q 14 Aug 2012

STANDARD BIOTOOLS INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $31.7M +$18.6M +142% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025
2023 $13.1M -$1.76M -11.8% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025
2022 $14.9M -$1.22M -7.58% 01 Jan 2022 31 Dec 2022 10-K 11 Mar 2025
2021 $16.1M +$1.65M +11.4% 01 Jan 2021 31 Dec 2021 10-K 14 Mar 2023
2020 $14.5M +$3.06M +26.8% 01 Jan 2020 31 Dec 2020 10-K 08 Mar 2022
2019 $11.4M +$370K +3.36% 01 Jan 2019 31 Dec 2019 10-K 08 Mar 2022
2018 $11M +$1.93M +21.2% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021
2017 $9.09M -$4.77M -34.4% 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
2016 $13.9M 01 Jan 2016 31 Dec 2016 10-K 18 Mar 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.